Impact of Menstrual Cycle-Based Resistance Training on Neuromuscular Performance in Female Athletes
Launched by UNIVERSITE DE LA REUNION · Nov 5, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how resistance training, adjusted according to different phases of the menstrual cycle, affects muscle performance in female athletes. The researchers want to find out if training at different intensities during specific times in the menstrual cycle can improve overall muscle strength and other important fitness measures, like jumping ability and how quickly muscles can generate force. They will compare women who have natural menstrual cycles with those who use birth control pills to see if the menstrual cycle affects training results.
To participate, women must be at least 18 years old, have regular menstrual cycles, and be physically active for at least three hours each week. Participants will attend two resistance training sessions each week for 13 weeks, with the intensity of the workouts tailored to their menstrual cycle phases. Throughout the study, they will undergo assessments to measure their muscle performance before and after the training. This trial is currently recruiting, and it’s a great opportunity for eligible female athletes looking to enhance their performance while also contributing to important research in women’s health.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Female athletes with natural menstrual cycles (eumenorrheic): Participants must have regular menstrual cycles lasting between 21 and 35 days, with at least 9 cycles per year.
- • Women using a low-dose monophasic estrogen-progestin oral contraceptive.
- • Age 18 or older: Participants must be legal adults.
- • Body Mass Index (BMI) between 18 and 30 kg/m².
- • No medical contraindications to high-level physical training or exercise.
- • Physically active: Engages in at least 3 hours of physical activity per week.
- • Informed consent: Provides written, informed consent to participate in the study.
- • Affiliation with a social security system (if applicable by local regulations).
- Exclusion Criteria:
- • -
About Universite De La Reunion
Université de La Réunion is a leading academic institution based in the Indian Ocean region, dedicated to advancing scientific research and education. With a strong emphasis on multidisciplinary collaboration, the university actively engages in clinical research initiatives aimed at addressing pressing health challenges. By leveraging its expertise in various fields, including medicine, biology, and public health, Université de La Réunion fosters innovative approaches to clinical trials, ensuring high standards of ethics and scientific rigor. The institution is committed to contributing valuable insights to the global healthcare landscape through its robust research programs and partnerships.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Le Tampon, France, Réunion
Patients applied
Trial Officials
Nicolas PEYROT, Professor (PU)
Study Director
Université du Mans
Manon DAUVERGNE, Professor (Assistant)
Study Director
Universite de La Reunion
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported